Long-bone critical-size defects treated with tissue-engineered polycaprolactone-co-lactide scaffolds: A pilot study on rats

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 3 A, 2010, Pages 964-972

  Rentsch, Claudia ^a   Rentsch, Barbe ^b   Breier, Annette ^c   Spekl, Kathrin ^d   Jung, Roland ^d   Manthey, Suzanne ^a   Scharnweber, Dieter ^e   Zwipp, Hans ^a   Biewener, Achim ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Catgut GmbH   (Germany)

^c LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^d Experimental Center   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Extracellular matrix; Femoral critical size defect; Nude rat; Polycaprolactone co lactide scaffold; Tissue engineering

Indexed keywords

BONE DEFECT; BONE FORMATION; BONE VOLUME; COLLAGEN I; COMPUTER TOMOGRAPHY; CRITICAL SIZE DEFECT; DEFECT RECONSTRUCTION; EXTRACELLULAR MATRICES; GROUP 4; HISTOLOGICAL ANALYSIS; MATRIX DEPOSITION; MESENCHYMAL STEM CELL; NUDE RAT; OSTEOGENIC POTENTIAL; PILOT STUDIES; POLYCAPROLACTONE-CO-LACTIDE; POLYCAPROLACTONE-CO-LACTIDE SCAFFOLD; SCAFFOLD MATERIALS; TRADE NAME;

BONE; CELL CULTURE; COLLAGEN; DEFECTS; LAND FILL; POLYCAPROLACTONE; RATS; STEM CELLS; TISSUE ENGINEERING; TOMOGRAPHY; WASTE DISPOSAL;

SCAFFOLDS;

CHONDROITIN SULFATE; COLLAGEN TYPE 1; POLYCAPROLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE DEFECT; BONE RADIOGRAPHY; BONE REMODELING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXPLANT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LONG BONE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; QUANTITATIVE ANALYSIS; RAT; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; CELLS, CULTURED; HUMANS; MATERIALS TESTING; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PILOT PROJECTS; POLYESTERS; RATS; RATS, NUDE; TISSUE SCAFFOLDS;

EID: 78249267853     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32878     Document Type: Review

References (31)

1. Hollinger JO, Brekke J, Gruskin E, Lee D,. Role of bone substitutes. Clin Orthop Relat Res 1996; 324: 55 -65.
2. Salgado AJ, Coutinho OP, Reis RL,. Bone tissue engineering: State of the art and future trends. Maccromol Biosci 2004; 4: 743 -765.
3. Hutmacher DW,. Scaffold design and fabrication technologies for engineering tissue-State of the art and future perspectives. J Biomater SciPolym Ed 2001; 12: 107 -124.
4. Williams JM, Adewunmi A, Schek RM, Flanagan CL, Krebsbach PH, Feinberg SE, Hollister SJ, Das S,. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005; 26: 4817 -4827.
5. Bramfeldt H, Sarazin P, Vermette P,. Chracterization, degradation, and mechanical strength of poly(D,L-lactide-co-ε-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-co-ε-caprolactone). J Biomed Mater Res A 2007; 83: 503 -511.
6. Tomihata K, Suzuki M, Oka T, Ikada Y,. A new resorbable monofilament suture. Polym Degrad Stab 1998; 59: 13 -18.
7. Wollenweber M, Domaschke H, Hanke T, Boxberger S, Schmack G, Gliesche K, Scharnweber D, Worch H,. Mimicked bioartificial matrix containing chondroitin sulphate on a textile scaffold of poly(3-hydroxybutyrate) alters the differentiation of adult human mesenchymal stem cells. Tissue Eng 2006; 12: 345 -359.
8. Rentsch B, Hofmann A, Breier A, Rentsch C, Scharnweber D,. Embroidered and Surface Modified Polycaprolactone-co-Lactide Scaffolds as Bioartificial Bone Substitute: In vitro Characterization. Ann Biomed Eng 2009; 37: 2118 -2128.
9. Rentsch C, Rentsch B, Breier A, Hofmann A, Manthey S, Scharnweber D, Biewener A, Zwipp H,. Evaluation of the osteogenic potential and vascularization of 3D poly(3)hydroxybutyrate scaffolds subcutaneously implanted in nude rats. J Biomed Mater Res A 2010; 92: 185 -195.
10. Rammelt S, Illert T, Bierbaum S, Scharnweber D, Zwipp H, Schneiders W,. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials 2006; 27: 5561 -5571.
11. Schneiders W, Reinstorf A, Ruhnow M, Rehberg S, Heineck J, Hinterseher I, Biewener A, Zwipp H, Rammelt S,. Effect of chondroitin sulphate on material properties and bone remodelling around hydroxyapatite/collagen composites. J Biomed Mater Res A 2008; 85: 638 -645.
12. Vögelin E, Jones NF, Huang JI, Brekke JH, Lieberman JR,. Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein. J Bone Joint Surg Am 2005; 87: 1323 -1331.
13. Rose T, Peng H, Usas A, Josten C, Fu FH, Huard J,. Ex-vivo gene therapy with BMP-4 for critically sized defects and enhancement of fracture healing in an osteoporotic animal model. [Article in German] Unfallchirurg 2005; 108: 25 -34.
14. Kirker-Head C, Karageorgiou V, Hofmann S, Fajardo R, Betz O, Merkle HP, Hilbe M, von Rechenberg B, McCool J, Abrahamsen L, Nazarian A, Cory E, Curtis M, Kaplan D, Meinel L,. BMP-silk composite matrices heal critically sized femoral defects. Bone 2007; 41: 247 -255.
15. Jäger M, Degistirici O, Knipper A, Fischer J, Sager M, Krauspe R,. Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation. J Bone Miner Res 2007; 22: 1224 -1233.
16. Chen X, Schmidt AH, Mahjouri S, Polly DW Jr, Lew WD,. Union of a chronically infected internally stabilized segmental defect in the rat femur after debridement and application of rhBMP-2 and systemic antibiotic. J Orthop Trauma 2007; 21: 693 -700.
17. Betz OB, Betz VM, Nazarian A, Pilapil CG, Vrahas MS, Bouxsein ML, Gerstenfeld LC, Einhorn TA, Evans CH,. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am 2006; 88: 355 -365.
18. Burg KJ, Porter S, Kellam JF,. Biomaterial developments for bone tissue engineering. Biomaterials 2000; 21: 2347 -2359.
19. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR,. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413 -3431.
20. Woodard JR, Hilldore AJ, Lan SK, Park CJ, Morgan AW, Eurell JA, Clark SG, Wheeler MB, Jamison RD, Wagoner Johnson AJ,. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 2007; 28: 45 -54.
21. Savarino L, Baldini N, Greco M, Capitani O, Pinna S, Valentini S, Lombardo B, Esposito MT, Pastore L, Ambrosio L, Battista S, Causa F, Zeppetelli S, Guarino V, Netti PA,. The performance of poly-epsilon-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials 2007; 28: 3101 -3109.
22. Remedios A,. Bone and bone healing. Vet Clin North Am Small Anim Pract 1999; 29: 1029 -1044.
23. Rüter A, Mayer E,. Pseudarthrosen. Chirurg 1999; 70: 1239 -1245.
24. Gerstenfeld LC, Alkhiary YM, Krall EA, Nicholls FH, Stapleton SN, Fitch JL, Bauer M, Kayal R, Graves DT, Jepsen KJ, Einhorn TA,. Three-dimensional reconstruction of fracture callus morphogenesis. J Histochem Cytochem 2006; 54: 1215 -1228.
25. Hutmacher DW, Schantz JT, Lam CX, Tan KC, Lim TC,. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007; 1: 245 -260.
26. Geuze RE, Everts PA, Kruyt MC, Verbout AJ, Alblas J, Dhert WJ,. Orthotopic location has limited benefit from allogeneic or autologous MSCs seeded on ceramic scaffolds. Tissue Eng Part A 2009; 15: 3231 -3239.
27. Bakker AD, Schrooten J, van Cleynenbreugel T, Vanlauwe J, Luyten J, Schepers E, Dubruel P, Schacht E, Lammens J, Luyten FP,. Quantitative screening of engineered implants in a long bone defect model in rabbits. Tissue Eng Part C Methods 2008; 14: 251 -260.
28. Kruyt MC, Dhert WJ, Oner FC, van Blitterswijk CA, Verbout AJ, de Bruijn JD,. Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 2007; 28: 1798 -1805.
29. Rammelt S, Heck C, Bernhardt R, Bierbaum S, Scharnweber D, Goebbels J, Ziegler J, Biewener A, Zwipp H,. In vivo effects of coating loaded and unloaded Ti implants with collagen, chondroitin sulfate, and hydroxyapatite in the sheep tibia. J Orthop Res 2007; 25: 1052 -1061.
30. Schneiders W, Reinstorf A, Biewener A, Serra A, Grass R, Kinscher M, Heineck J, Rehberg S, Zwipp H, Rammelt S,. In vivo effects of modification of hydroxyapatite/collagen composites with and without chondroitin sulphate on bone remodeling in the sheep tibia. J Orthop Res 2009; 27: 15 -21.
31. Gerstenfeld LC, Cullinane DM, Barnes GL,. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003; 88: 873 -884.